IL11 and breast carcinoma: Since the initial study showing the expression of IL-11 in breast tumor tissues more than 25 years ago[27], numerous investigations have been subsequently undertaken to address the regulation and pathological significance of IL-11 expression in breast cancer and, in particular, in the tumor-induced osteolysis[5,13,28-34].